Atlas Trials

Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Clinical trial NCT02569957 · TERMINATED

Trial details

NCT number
NCT02569957
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Ovarian Endometrioid TumorMalignant Ovarian Serous TumorRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Start date
2015-10-02
Primary completion
2016-06-10
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.